Nu Skin Enterprises with ticker code (NUS) now have 5 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 70 and 59 with a mean TP of 65.2. With the stocks previous close at 40.94 this is indicating there is a potential upside of 59.3%. The 50 day MA is 49.57 and the 200 day MA is 54.15. The market cap for the company is $2,069m. Visit the company website at: http://www.nuskin.com
Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises was founded in 1984 and is headquartered in Provo, Utah.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.
